AbbVie’s Skyrizi took home the top spot for most pharma brand ad impressions in April 2025, according to data released by ...

AbbVie snagged yet another spot among April’s highest TV ad spenders, as its Vraylar jumped two spots to eighth place with a ...

Pharma giant AbbVie has been taken to task by the FDA for running an ad for one of its migraine drugs, featuring tennis star Serena Williams, which the agency says overstates its efficacy.

Advertisement Article continues below this ad The drugmaker posted revenue of $13.34 billion in the period, which also beat Street forecasts. Seven analysts surveyed by Zacks expected $12.91 billion.

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV ... starting a business often meant renting a ...

AbbVie is poised to grow this year for the first ... Kennedy has floated the idea of banning pharmaceutical companies from placing TV ads in the United States. It sounds scary, but pharmaceutical ...

Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or ...

AbbVie Inc. (NYSE:ABBV ... These stocks are handpicked by our research director, Dr. Inan Dogan. • Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE ... renting a physical storefront and paying for newspaper ads. Today, it’s a different story—entrepreneurs can build ...

Shares of AbbVie Inc. ABBV slipped 1.64% to $170.16 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 2.36% to 5,158.20 and ...